BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 1697609)

  • 41. [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].
    Jaśkiewicz E
    Postepy Hig Med Dosw (Online); 2004; 58():472-82. PubMed ID: 15765008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
    Elong Ngono A; Pettré S; Salou M; Bahbouhi B; Soulillou JP; Brouard S; Laplaud DA
    Clin Immunol; 2012 Aug; 144(2):117-26. PubMed ID: 22717772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma.
    Olsson T
    J Neuroimmunol; 1992 Oct; 40(2-3):211-8. PubMed ID: 1430152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myelin antigen reactive T cells in cerebrovascular diseases.
    Wang WZ; Olsson T; Kostulas V; Höjeberg B; Ekre HP; Link H
    Clin Exp Immunol; 1992 Apr; 88(1):157-62. PubMed ID: 1373351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis.
    Hafler DA; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Fukaura H
    Ann N Y Acad Sci; 1997 Dec; 835():120-31. PubMed ID: 9616767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.
    Diaz-Villoslada P; Shih A; Shao L; Genain CP; Hauser SL
    J Neuroimmunol; 1999 Sep; 99(1):36-43. PubMed ID: 10496175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoreactivity to myelin antigens related to HLA associations with multiple sclerosis.
    Yentür SP; Akman-Demir G; Eraksoy M; Saruhan-Direskeneli G
    Mult Scler; 2002 Aug; 8(4):278-83. PubMed ID: 12166496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
    Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
    Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
    van Nierop GP; Janssen M; Mitterreiter JG; van de Vijver DA; de Swart RL; Haagmans BL; Verjans GM; Hintzen RQ
    Eur J Immunol; 2016 Feb; 46(2):347-53. PubMed ID: 26507805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple sclerosis:cerebrospinal fluid.
    Olsson T
    Ann Neurol; 1994; 36 Suppl():S100-2. PubMed ID: 8017866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis.
    Stinissen P; Medaer R; Raus J
    Mult Scler; 1998 Jun; 4(3):203-11. PubMed ID: 9762675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases.
    Lisak RP; Zweiman B
    N Engl J Med; 1977 Oct; 297(16):850-3. PubMed ID: 904660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune regulation of multiple sclerosis by transdermally applied myelin peptides.
    Juryńczyk M; Walczak A; Jurewicz A; Jesionek-Kupnicka D; Szczepanik M; Selmaj K
    Ann Neurol; 2010 Nov; 68(5):593-601. PubMed ID: 21031576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
    Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA
    J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes.
    Hong J; Zang YCQ; Li S; Rivera VM; Zhang JZ
    Eur J Immunol; 2004 Mar; 34(3):870-881. PubMed ID: 14991617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis.
    Olsson T; Sun J; Hillert J; Höjeberg B; Ekre HP; Andersson G; Olerup O; Link H
    Eur J Immunol; 1992 Apr; 22(4):1083-7. PubMed ID: 1372558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune tolerance to myelin proteins.
    Seamons A; Perchellet A; Goverman J
    Immunol Res; 2003; 28(3):201-21. PubMed ID: 14713715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple sclerosis: occurrence of myelin basic protein peptide-reactive T cells in healthy family members.
    Fredrikson S; Söderström M; Hillert J; Sun JB; Käll TB; Link H
    Acta Neurol Scand; 1994 Mar; 89(3):184-9. PubMed ID: 7518178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tovaxin, radiation-attenuated, patient-specific T-cells for the therapeutic vaccination of multiple sclerosis.
    Hellings N; Stinissen P
    Curr Opin Investig Drugs; 2008 May; 9(5):534-40. PubMed ID: 18465664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients.
    Pelfrey CM; Trotter JL; Tranquill LR; McFarland HF
    J Neuroimmunol; 1994 Sep; 53(2):153-61. PubMed ID: 7520919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.